The first patient with hepatocellular carcinoma (HCC) has begun treatment in phase 2a with the candidate drug fostroxacitabine bralpamide (fostrox) in combination with Lenvima, according to Medivir AB, a pharmaceutical company dedicated to creating novel cancer treatments in regions with…
Category: Pharma News
BRIDGEWATER, N.J.–(BUSINESS WIRE)– Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for naloxone hydrochloride nasal spray, USP, 4mg, which is the generic version of Narcan® and…
One of the top manufacturers of minimally invasive structural heart disease devices, Occlutech Holding AG (Occlutech), has announced the enrollment of the first patient in the FROST-HF study. In the FROST-HF study, patients with heart failure with either preserved ejection…
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Lenalidomide Capsules, 2.5 mg and 20 mg (USRLD: Revlimid® Capsules). Lenalidomide Capsules are used to…
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged its member companies to submit their expressions of interest (EOI) to export levothyroxine and levonorgestrel from India if they have operations in Latin American Countries (LAC) or are interested in…
According to the 2017 Medical Devices Regulations (MDR), the Central Drugs Standard Control Organization (CDSCO) has authorised two more Medical Device Testing Labs (MDTL) to conduct tests or evaluations of medical devices on behalf of the manufacturers. With this, there…
Zavzpret (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray, has been approved by the US Food and Drug Administration (FDA) for the immediate treatment of migraine in adults with or without aura. Zavzpret was statistically…
Statistically significant and clinically meaningful improvements in overall survival (OS), a crucial secondary endpoint, were seen with AstraZeneca’s Tagrisso (osimertinib) compared to placebo in the adjuvant treatment of patients with early-stage (IB, II, and IIIA) epidermal growth factor receptor-mutated (EGFRm)…
Researchers from the Department of Organic Chemistry (DOC) and the Materials Research Center (MRC) at the Indian Institute of Science (IISc) have demonstrated that surface modifications of two-dimensional molybdenum disulphide (2D-MoS) nanosheets can greatly increase their effectiveness for uses like…
A group of pharmacists from the state of Maharashtra who have a degree and higher education credentials (B Pharm, M Pharm, and Pharm D) have complained that the upper age limit of 25 is being purposefully imposed on the position…